159 related articles for article (PubMed ID: 36051794)
21. High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
Xing Y; Luo DY; Long MY; Zeng SL; Li HH
World J Surg Oncol; 2014 Feb; 12():29. PubMed ID: 24485040
[TBL] [Abstract][Full Text] [Related]
22. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
[TBL] [Abstract][Full Text] [Related]
24. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.
Tulake W; Yuemaier R; Sheng L; Ru M; Lidifu D; Abudula A
Oncol Lett; 2018 Nov; 16(5):5525-5534. PubMed ID: 30344706
[TBL] [Abstract][Full Text] [Related]
26. Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Yassin Fel-Z
Pathol Res Pract; 2016 May; 212(5):398-409. PubMed ID: 26907783
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.
Kahlert C; Gaitzsch E; Steinert G; Mogler C; Herpel E; Hoffmeister M; Jansen L; Benner A; Brenner H; Chang-Claude J; Rahbari N; Schmidt T; Klupp F; Grabe N; Lahrmann B; Koch M; Halama N; Büchler M; Weitz J
Ann Surg Oncol; 2012 Dec; 19(13):4193-201. PubMed ID: 22878609
[TBL] [Abstract][Full Text] [Related]
28. High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Ye Y; Zhang S; Chen Y; Wang X; Wang P
Pathol Res Pract; 2018 Feb; 214(2):268-272. PubMed ID: 29103772
[TBL] [Abstract][Full Text] [Related]
29. Expression of aldehyde dehydrogenase family 1 member A1 and high mobility group box 1 in oropharyngeal squamous cell carcinoma in association with survival time.
Qian X; Coordes A; Kaufmann AM; Albers AE
Oncol Lett; 2016 Nov; 12(5):3429-3434. PubMed ID: 27900016
[TBL] [Abstract][Full Text] [Related]
30. Aldehyde dehydrogenase 1A1 increases NADH levels and promotes tumor growth via glutathione/dihydrolipoic acid-dependent NAD
Wang B; Chen X; Wang Z; Xiong W; Xu T; Zhao X; Cao Y; Guo Y; Li L; Chen S; Huang S; Wang X; Fang M; Shen Z
Oncotarget; 2017 Sep; 8(40):67043-67055. PubMed ID: 28978015
[TBL] [Abstract][Full Text] [Related]
31. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
[TBL] [Abstract][Full Text] [Related]
32. ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
van der Waals LM; Borel Rinkes IHM; Kranenburg O
PLoS One; 2018; 13(10):e0205536. PubMed ID: 30308036
[TBL] [Abstract][Full Text] [Related]
33. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
34. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
[TBL] [Abstract][Full Text] [Related]
36. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
37. Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression.
Ge X; Li M; Song GX; Zhang Z; Yin J; Ge Z; Shi Z; Liu LZ; Jiang BH; Qian X; Shen H
Clin Transl Med; 2022 Dec; 12(12):e1136. PubMed ID: 36504325
[TBL] [Abstract][Full Text] [Related]
38. ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Adam SA; Schnell O; Pöschl J; Eigenbrod S; Kretzschmar HA; Tonn JC; Schüller U
Brain Pathol; 2012 Nov; 22(6):788-97. PubMed ID: 22417385
[TBL] [Abstract][Full Text] [Related]
39. Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.
Schäfer A; Teufel J; Ringel F; Bettstetter M; Hoepner I; Rasper M; Gempt J; Koeritzer J; Schmidt-Graf F; Meyer B; Beier CP; Schlegel J
Neuro Oncol; 2012 Dec; 14(12):1452-64. PubMed ID: 23132408
[TBL] [Abstract][Full Text] [Related]
40. Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis.
Xu SL; Liu S; Cui W; Shi Y; Liu Q; Duan JJ; Yu SC; Zhang X; Cui YH; Kung HF; Bian XW
Am J Cancer Res; 2015; 5(4):1471-83. PubMed ID: 26101711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
